Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Motor Activity 6Polycystic Ovary Syndrome 2Obesity 2Diabetes Mellitus 2Stroke 1Sedentary Behavior 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Heart Failure 1Frailty 1Endometrial Neoplasms 1Diabetes Mellitus, Type 2 1Cardiovascular Diseases 1Breast Neoplasms 1Body Weight 1Arthritis 1

Interventions

Doxorubicin 33Ifosfamide 23Gemcitabine 19pazopanib 18Cyclophosphamide 16Radiotherapy 15pembrolizumab 13Filgrastim 12Docetaxel 12Bevacizumab 10Vincristine 9Sirolimus 9Irinotecan 9Etoposide 9olaratumab 7eribulin 7Sorafenib 7Radiation 7temsirolimus 6Temozolomide 6Mesna 6Magnetic Resonance Spectroscopy 6Cisplatin 6tazemetostat 5cixutumumab 5Trabectedin 5Radiosurgery 5Nivolumab 5Ipilimumab 5Granulocyte Colony-Stimulating Factor 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma × Resistance Training × Clear all
NCT04247425 2022-08-08

Progressive Resistance Training for the Improvement of Physical Function

OHSU Knight Cancer Institute

Phase NA Completed
10 enrolled 12 charts
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡